Comprehensive Cancer Centers Clinical Research

In the modern age, every advancement in cancer treatment has come through conducting clinical research. Comprehensive Cancer Centers prides itself on offering the latest in cancer treatment and research to patients. The practice participates in more than 170  studies each year and has played a role in developing more than 100 FDA-approved cancer therapies, of which include OPDIVO®, KEYTRUDA®, TECENTRIQ®, PROVENGE®, Xofigo®, Herceptin® and others.

Clinical research offers high-quality care, provides patients with the opportunity to take an active role in their treatment plans, and allows patients to help others by improving cancer treatment for future patients. The purpose of clinical trials is first and foremost to better the care for patients going through cancer treatment. Each year, clinical trials treat thousands of people. You can learn more about the benefits here. 

All advancements in cancer treatment over the past 50 years have come by way of doing research.

Clinical Research Affiliations

Comprehensive partners with institutions such as UCLA TRIO-US, Sarah Cannon Research Institute (formerly US Oncology Research), USC, Memorial Sloan Kettering Cancer Center and leading pharmaceutical companies to bring groundbreaking treatments close to home, some of which are not available anywhere else in the world.

Right Here in Nevada

Comprehensive has developed one of the largest Phase I research programs in Nevada, with extensive research programs for breast cancer, gastrointestinal malignancies, genitourinary malignancies and skin cancer. All right here in Nevada.

Call 702-952-3350 now or fill out our contact form for more information.